"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","24/35","481/2914",7.003287961482e-12,3.60669330016323e-09,2.11573015257404e-09,"MYB/AR/CDK1/MAPK1/E2F1/SMAD3/CREB1/NR0B2/PPP2CA/SRC/CSNK2A1/STK11/CDK2/GATA1/TP53/SUMO1/CTNNB1/CDK5/ZNF521/MAX/STAT1/AKT3/AKT1/AKT2",24
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","24/35","499/2914",1.59876475744452e-11,4.11681925041964e-09,2.41497623887672e-09,"MYB/AR/CDK1/MAPK1/E2F1/SMAD3/CREB1/NR0B2/PPP2CA/SRC/CSNK2A1/STK11/CDK2/GATA1/TP53/SUMO1/CTNNB1/CDK5/ZNF521/MAX/STAT1/AKT3/AKT1/AKT2",24
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","10/35","77/2914",9.88771539178476e-09,1.49046380577907e-06,8.74324194703309e-07,"CDK1/E2F1/PPP2CA/SRC/CDK2/MAX/JAK2/AKT3/AKT1/AKT2",10
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","14/35","191/2914",1.15764179089637e-08,1.49046380577907e-06,8.74324194703309e-07,"CDK1/MAPK1/E2F1/PPP2CA/SRC/CSNK2A1/CDK2/CSNK1D/TP53/MAX/JAK2/AKT3/AKT1/AKT2",14
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","9/35","62/2914",2.25689160171913e-08,1.82321597021201e-06,1.06952066111568e-06,"AR/CDK1/MAPK1/SRC/ZNF521/STAT1/AKT3/AKT1/AKT2",9
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","7/35","29/2914",2.47815762941439e-08,1.82321597021201e-06,1.06952066111568e-06,"CDK1/PPP2CA/CDK2/TP53/AKT3/AKT1/AKT2",7
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","7/35","29/2914",2.47815762941439e-08,1.82321597021201e-06,1.06952066111568e-06,"CDK1/PPP2CA/CDK2/TP53/AKT3/AKT1/AKT2",7
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","15/35","249/2914",4.29307969212394e-08,2.76367005180479e-06,1.62120246268365e-06,"CDK1/MAPK1/E2F1/PPP2CA/SRC/CSNK2A1/CDK2/CSNK1D/TP53/SUMO1/MAX/JAK2/AKT3/AKT1/AKT2",15
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","10/35","95/2914",7.8857203911337e-08,4.51238444603761e-06,2.64701959328114e-06,"CDK1/PPP2CA/CSNK2A1/STK11/CDK2/TP53/CDK5/AKT3/AKT1/AKT2",10
"R-HSA-69206","R-HSA-69206","G1/S Transition","8/35","60/2914",3.05672608186558e-07,1.57421393216077e-05,9.23453037363601e-06,"CDK1/E2F1/PPP2CA/CDK2/MAX/AKT3/AKT1/AKT2",8
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","12/35","201/2914",1.70464302614422e-06,7.98082871331155e-05,4.68165118185062e-05,"MAPK1/EGR1/CREB1/GSK3A/PPP2CA/SRC/PRKCD/CSNK2A1/TP53/AKT3/AKT1/AKT2",12
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","5/35","19/2914",1.91702339708623e-06,8.22722541249507e-05,4.82619048213814e-05,"PPP2CA/SRC/AKT3/AKT1/AKT2",5
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","11/35","172/2914",2.66016714612958e-06,0.000105383544635133,6.18192689019586e-05,"MAPK1/EGR1/CREB1/GSK3A/PPP2CA/SRC/CSNK2A1/TP53/AKT3/AKT1/AKT2",11
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","4/35","10/2914",3.483920995661e-06,0.000123097663181128,7.22105862707897e-05,"TP53/AKT3/AKT1/AKT2",4
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","16/35","397/2914",3.5853688305183e-06,0.000123097663181128,7.22105862707897e-05,"MYB/MAPK1/E2F1/SMAD3/CREB1/SRC/CSNK2A1/RELA/CDK2/CTNNB1/CDK5/PIAS2/AKT3/KDM6A/AKT1/AKT2",16
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","7/35","59/2914",4.19555601835012e-06,0.000135044459340645,7.92187221885845e-05,"MAPK1/EGR1/CSNK2A1/TP53/AKT3/AKT1/AKT2",7
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","6/35","39/2914",4.71300194760078e-06,0.000142776235471435,8.37542760966826e-05,"E2F1/CDK2/MAX/AKT3/AKT1/AKT2",6
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","6/35","40/2914",5.49713391905164e-06,0.000157279109350644,9.22618382905158e-05,"E2F1/CDK2/MAX/AKT3/AKT1/AKT2",6
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","5/35","24/2914",6.71115572669813e-06,0.000172812259962477,0.000101373773345388,"CREB1/GSK3A/AKT3/AKT1/AKT2",5
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","5/35","24/2914",6.71115572669813e-06,0.000172812259962477,0.000101373773345388,"MAPK1/CREB1/AKT3/AKT1/AKT2",5
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","11/35","194/2914",8.71484189307637e-06,0.00021372112261592,0.000125371409689871,"CDK1/E2F1/PPP2CA/CSNK2A1/STK11/CDK2/TP53/CDK5/AKT3/AKT1/AKT2",11
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","4/35","13/2914",1.1561382273477e-05,0.000270641448674576,0.000158761565190809,"GSK3A/AKT3/AKT1/AKT2",4
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","4/35","14/2914",1.60480880476759e-05,0.000359337623676221,0.000210791820122791,"TP53/AKT3/AKT1/AKT2",4
"R-HSA-109581","R-HSA-109581","Apoptosis","8/35","101/2914",1.71002340294996e-05,0.000366942521883011,0.000215252945897648,"MAPK1/E2F1/PRKCD/TP53/CTNNB1/AKT3/AKT1/AKT2",8
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","5/35","29/2914",1.79581365464104e-05,0.000367069832656186,0.000215327627945479,"E2F1/TP53/AKT3/AKT1/AKT2",5
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","6/35","49/2914",1.85316808719628e-05,0.000367069832656186,0.000215327627945479,"MAPK1/E2F1/TP53/AKT3/AKT1/AKT2",6
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","8/35","103/2914",1.97810968959321e-05,0.000377306107459445,0.000221332351233236,"MAPK1/E2F1/PRKCD/TP53/CTNNB1/AKT3/AKT1/AKT2",8
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","8/35","108/2914",2.80754082183117e-05,0.000516386972586804,0.000302918878144942,"MYB/MAPK1/CREB1/SRC/FOXA1/AKT3/AKT1/AKT2",8
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","12/35","268/2914",3.47206196030366e-05,0.000616590313640133,0.000361699376626915,"MAPK1/SMAD3/CREB1/GSK3A/PPP2CA/SRC/CTNNB1/JAK2/STAT1/AKT3/AKT1/AKT2",12
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","4/35","19/2914",5.95394945703991e-05,0.00098912386141147,0.000580232086305757,"CDK1/E2F1/CDK2/MAX",4
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","4/35","19/2914",5.95394945703991e-05,0.00098912386141147,0.000580232086305757,"AR/MAPK1/SRC/ZNF521",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","6/35","62/2914",7.28203449957862e-05,0.00117195242727593,0.000687481546506271,"MYB/CDK2/GATA1/TP53/CDK5/JAK2",6
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","6/35","63/2914",7.97934526317612e-05,0.00124526145773809,0.000730485515321068,"MAPK1/CREB1/SRC/AKT3/AKT1/AKT2",6
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","6/35","68/2914",0.00012310458718653,0.00186467242356068,0.00109383952082149,"CDK1/E2F1/PPP2CA/CDK2/CSNK1D/TP53",6
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","5/35","44/2914",0.000144261870075411,0.00211755981513305,0.00124218634020069,"SRC/PRKCD/AKT3/AKT1/AKT2",5
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","8/35","136/2914",0.000148023598727747,0.00211755981513305,0.00124218634020069,"MYB/MAPK1/CREB1/SRC/FOXA1/AKT3/AKT1/AKT2",8
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","4/35","24/2914",0.000156398090693995,0.00212720084754275,0.00124784188706136,"AR/MAPK1/SRC/ZNF521",4
"R-HSA-69242","R-HSA-69242","S Phase","6/35","71/2914",0.000156958509139077,0.00212720084754275,0.00124784188706136,"E2F1/CDK2/MAX/AKT3/AKT1/AKT2",6
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","7/35","104/2914",0.000177698651964257,0.00231880699393553,0.00136024038274808,"HIF1A/E2F1/SMAD3/CREB1/TP53/STAT1/AKT1",7
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/35","25/2914",0.000184604051944382,0.00231880699393553,0.00136024038274808,"CTNNB1/AKT3/AKT1/AKT2",4
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","4/35","25/2914",0.000184604051944382,0.00231880699393553,0.00136024038274808,"CSNK2A1/AKT3/AKT1/AKT2",4
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","5/35","49/2914",0.000242591087719896,0.00268842596933488,0.00157706336882803,"SMAD3/STK11/AKT3/AKT1/AKT2",5
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/35","11/2914",0.000245351496230562,0.00268842596933488,0.00157706336882803,"CDK1/E2F1/PPP2CA",3
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","3/35","11/2914",0.000245351496230562,0.00268842596933488,0.00157706336882803,"AKT3/AKT1/AKT2",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/35","11/2914",0.000245351496230562,0.00268842596933488,0.00157706336882803,"AKT3/AKT1/AKT2",3
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","3/35","11/2914",0.000245351496230562,0.00268842596933488,0.00157706336882803,"E2F1/CDK2/TP53",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/35","11/2914",0.000245351496230562,0.00268842596933488,0.00157706336882803,"AKT3/AKT1/AKT2",3
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/35","27/2914",0.000251771756643038,0.0027013011389826,0.00158461609992438,"MYB/E2F1/CREB1/CDK2",4
"R-HSA-1643685","R-HSA-1643685","Disease","14/35","443/2914",0.00030748768818568,0.00323175835542092,0.0018957887542275,"MAPK1/SMAD3/CREB1/GSK3A/PPP2CA/SRC/RELA/CTNNB1/CDK5/JAK2/STAT1/AKT3/AKT1/AKT2",14
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","5/35","53/2914",0.000352670591146478,0.00363250708880873,0.00213087283492714,"PPP2CA/SRC/AKT3/AKT1/AKT2",5
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/35","30/2914",0.000383204990129462,0.00386961901797398,0.00226996557620548,"CDK1/E2F1/CDK2/TP53",4
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/35","13/2914",0.000418309302615694,0.00408474399789283,0.00239616050566222,"AKT3/AKT1/AKT2",3
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","6/35","85/2914",0.000424644325980903,0.00408474399789283,0.00239616050566222,"SRC/PRKCD/CTNNB1/AKT3/AKT1/AKT2",6
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","12/35","347/2914",0.000435139705758501,0.00408474399789283,0.00239616050566222,"MAPK1/CREB1/PPP2CA/SRC/PRKCD/CTNNB1/CDK5/JAK2/STAT1/AKT3/AKT1/AKT2",12
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","4/35","31/2914",0.000436234795891468,0.00408474399789283,0.00239616050566222,"SRC/AKT3/AKT1/AKT2",4
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/35","56/2914",0.00045742008572199,0.00420663114547902,0.00246766098876337,"CSNK2A1/STK11/CDK2/TP53/CDK5",5
"R-HSA-109582","R-HSA-109582","Hemostasis","11/35","298/2914",0.000467537023181021,0.0042242380164601,0.00247798939340633,"MYB/MAPK1/PPP2CA/SRC/PRKCD/CDK2/GATA1/TP53/CDK5/JAK2/AKT1",11
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","3/35","14/2914",0.00052801690658879,0.0046089611337835,0.00270367265282752,"MAPK1/PPP2CA/SRC",3
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","3/35","14/2914",0.00052801690658879,0.0046089611337835,0.00270367265282752,"SUMO1/JAK2/STAT1",3
"R-HSA-111885","R-HSA-111885","Opioid Signalling","5/35","59/2914",0.000584163590360765,0.00501407081726324,0.00294131491988666,"MAPK1/CREB1/PPP2CA/PRKCD/CDK5",5
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","6/35","92/2914",0.000651634750815608,0.00543737650767941,0.00318963118590494,"SRC/PRKCD/CTNNB1/AKT3/AKT1/AKT2",6
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/35","15/2914",0.000654596783448783,0.00543737650767941,0.00318963118590494,"AKT3/AKT1/AKT2",3
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","4/35","35/2914",0.000701553579534582,0.00573492211841761,0.00336417505975648,"TP53/AKT3/AKT1/AKT2",4
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","3/35","16/2914",0.000799038304513446,0.006330841951145,0.0037137488808965,"TP53/SUMO1/PIAS2",3
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/35","16/2914",0.000799038304513446,0.006330841951145,0.0037137488808965,"AKT3/AKT1/AKT2",3
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","6/35","97/2914",0.000864762551664654,0.0067477683955651,0.00395832300363247,"CREB1/GSK3A/SRC/AKT3/AKT1/AKT2",6
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","6/35","99/2914",0.000963744088784384,0.00740788366752176,0.0043455546501354,"MAPK1/PPP2CA/SRC/AKT3/AKT1/AKT2",6
"R-HSA-69275","R-HSA-69275","G2/M Transition","5/35","66/2914",0.000981562140083132,0.00743388973739431,0.00436081012699472,"CDK1/PPP2CA/CDK2/CSNK1D/TP53",5
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/35","18/2914",0.00114526816194124,0.0085109560564322,0.00499263032845384,"CDK1/PPP2CA/CDK2",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","4/35","40/2914",0.0011733551068091,0.0085109560564322,0.00499263032845384,"E2F1/PPP2CA/SRC/JAK2",4
"R-HSA-69236","R-HSA-69236","G1 Phase","4/35","40/2914",0.0011733551068091,0.0085109560564322,0.00499263032845384,"E2F1/PPP2CA/SRC/JAK2",4
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/35","21/2914",0.0018210969964003,0.0128474651115912,0.007536479278542,"AKT3/AKT1/AKT2",3
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","3/35","21/2914",0.0018210969964003,0.0128474651115912,0.007536479278542,"AKT3/AKT1/AKT2",3
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","4/35","47/2914",0.0021573230278506,0.0150138021532846,0.00880727893304583,"PRKCD/SUMO1/JAK2/STAT1",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/35","23/2914",0.0023853301066914,0.0161637500650799,0.00948185236316388,"CDK1/MAPK1/JAK2",3
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/35","23/2914",0.0023853301066914,0.0161637500650799,0.00948185236316388,"MAPK1/E2F1/TP53",3
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","3/35","24/2914",0.0027037489661196,0.0174053839693949,0.0102102099115306,"AKT3/AKT1/AKT2",3
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","3/35","24/2914",0.0027037489661196,0.0174053839693949,0.0102102099115306,"MAPK1/CREB1/PPP2CA",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/35","24/2914",0.0027037489661196,0.0174053839693949,0.0102102099115306,"AKT3/AKT1/AKT2",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/35","24/2914",0.0027037489661196,0.0174053839693949,0.0102102099115306,"MAPK1/JAK2/STAT1",3
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/35","25/2914",0.00304726872714349,0.0193746098083815,0.0113653817373643,"AKT3/AKT1/AKT2",3
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","4/35","53/2914",0.0033651865062518,0.0211350128136546,0.0123980555493487,"SMAD3/SRC/TP53/CTNNB1",4
"R-HSA-111996","R-HSA-111996","Ca-dependent events","3/35","26/2914",0.00341652390692786,0.0211989133984078,0.0124355404094901,"MAPK1/CREB1/PRKCD",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","5/35","89/2914",0.00373686142988577,0.0228283806016562,0.0133914056876348,"MAPK1/CREB1/PPP2CA/SRC/CDK5",5
"R-HSA-165159","R-HSA-165159","mTOR signalling","3/35","27/2914",0.00381211792571346,0.0228283806016562,0.0133914056876348,"STK11/AKT1/AKT2",3
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","3/35","27/2914",0.00381211792571346,0.0228283806016562,0.0133914056876348,"MAPK1/PPP2CA/SRC",3
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","6/35","130/2914",0.00391965325112608,0.0232025451072406,0.0136108951370016,"AR/MAPK1/PPP2CA/SRC/PRKCD/CTNNB1",6
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","4/35","56/2914",0.00411447131415991,0.024079008259004,0.0141250390809078,"CDK1/PPP2CA/CSNK2A1/CSNK1D",4
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","3/35","28/2914",0.00423462384795922,0.0242314586855445,0.014214468355138,"AR/SUMO1/PIAS2",3
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","3/35","28/2914",0.00423462384795922,0.0242314586855445,0.014214468355138,"MAPK1/PPP2CA/SRC",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","10/35","332/2914",0.00431554650006234,0.0244231477750781,0.0143269155062798,"HIF1A/MAPK1/SMAD3/CREB1/PPP2CA/RELA/TP53/JAK2/STAT1/AKT1",10
"R-HSA-5673000","R-HSA-5673000","RAF activation","3/35","29/2914",0.00468458511000016,0.026208073472496,0.0153739746277084,"PPP2CA/SRC/JAK2",3
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","5/35","94/2914",0.00473272006396529,0.026208073472496,0.0153739746277084,"HIF1A/TP53/JAK2/STAT1/AKT1",5
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","3/35","30/2914",0.00516251623443024,0.0279862722182271,0.0164170876374679,"MAPK1/CREB1/PPP2CA",3
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","3/35","30/2914",0.00516251623443024,0.0279862722182271,0.0164170876374679,"MAPK1/PPP2CA/SRC",3
"R-HSA-913531","R-HSA-913531","Interferon Signaling","5/35","97/2914",0.0054143313683361,0.0288501029247199,0.0169238212353492,"EGR1/PRKCD/SUMO1/JAK2/STAT1",5
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","3/35","31/2914",0.00566890353141653,0.0288501029247199,0.0169238212353492,"CTNNB1/AKT1/AKT2",3
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","7/35","187/2914",0.00578287998789886,0.0288501029247199,0.0169238212353492,"HIF1A/AR/MAPK1/E2F1/RELA/CDK2/TP53",7
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","5/35","99/2914",0.00590593240920225,0.0288501029247199,0.0169238212353492,"MAPK1/E2F1/RELA/CDK2/TP53",5
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","4/35","62/2914",0.00593798934334313,0.0288501029247199,0.0169238212353492,"CDK1/CDK2/TP53/SUMO1",4
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/35","10/2914",0.00593807943693264,0.0288501029247199,0.0169238212353492,"CDK1/JAK2",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/35","10/2914",0.00593807943693264,0.0288501029247199,0.0169238212353492,"E2F1/PPP2CA",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/35","10/2914",0.00593807943693264,0.0288501029247199,0.0169238212353492,"CDK1/E2F1",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","2/35","10/2914",0.00593807943693264,0.0288501029247199,0.0169238212353492,"RELA/SUMO1",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/35","10/2914",0.00593807943693264,0.0288501029247199,0.0169238212353492,"SRC/CSNK2A1",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/35","10/2914",0.00593807943693264,0.0288501029247199,0.0169238212353492,"JAK2/STAT1",2
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","7/35","189/2914",0.0061301583711053,0.0290469634580114,0.0170393020182918,"HIF1A/AR/MAPK1/E2F1/RELA/CDK2/TP53",7
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/35","32/2914",0.00620420578714807,0.0290469634580114,0.0170393020182918,"MAPK1/CREB1/SRC",3
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","3/35","32/2914",0.00620420578714807,0.0290469634580114,0.0170393020182918,"MAPK1/PPP2CA/SRC",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/35","32/2914",0.00620420578714807,0.0290469634580114,0.0170393020182918,"MAPK1/EGR1/TP53",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/35","33/2914",0.00676885493961992,0.0314050476928312,0.0184225829082116,"CDK1/MAPK1/PPP2CA",3
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/35","11/2914",0.00720313009042199,0.0325404561102397,0.0190886272941008,"JAK2/STAT1",2
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/35","11/2914",0.00720313009042199,0.0325404561102397,0.0190886272941008,"E2F1/MAX",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/35","11/2914",0.00720313009042199,0.0325404561102397,0.0190886272941008,"JAK2/STAT1",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","3/35","34/2914",0.00736325674195048,0.0326903208802112,0.0191765397907422,"MAPK1/CREB1/PRKCD",3
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","3/35","34/2914",0.00736325674195048,0.0326903208802112,0.0191765397907422,"MAPK1/CREB1/PRKCD",3
"R-HSA-68886","R-HSA-68886","M Phase","5/35","105/2914",0.00757048526492682,0.0333230761661309,0.0195477217366981,"CDK1/MAPK1/PPP2CA/CSNK2A1/CSNK1D",5
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","5/35","107/2914",0.0081919353816344,0.0357529383181501,0.0209731084257723,"AR/RELA/TP53/SUMO1/PIAS2",5
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","5/35","108/2914",0.00851570417471669,0.0368176385241241,0.021597674514918,"PPP2CA/CSNK2A1/CTNNB1/AKT1/AKT2",5
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/35","12/2914",0.00857886722892212,0.0368176385241241,0.021597674514918,"MAPK1/PPP2CA",2
"R-HSA-2990846","R-HSA-2990846","SUMOylation","5/35","109/2914",0.00884833094398999,0.0376602515384698,0.0220919615565474,"AR/RELA/TP53/SUMO1/PIAS2",5
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","4/35","70/2914",0.00911804719613492,0.0384901172623728,0.0225787708825774,"MAPK1/CREB1/PPP2CA/SRC",4
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","3/35","37/2914",0.00932865639371677,0.0390590084777572,0.0229124893880763,"MAPK1/PPP2CA/SRC",3
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","3/35","38/2914",0.0100456251633806,0.0417217496704921,0.0244744857545861,"MAPK1/PPP2CA/SRC",3
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","5/35","114/2914",0.0106485176828254,0.0438718928532408,0.0257357858944918,"CDK1/PPP2CA/CDK2/TP53/SUMO1",5
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/35","14/2914",0.0116517030548912,0.0458063135364042,0.0268705405926377,"PPP2CA/CTNNB1",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/35","14/2914",0.0116517030548912,0.0458063135364042,0.0268705405926377,"PPP2CA/CTNNB1",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0458063135364042,0.0268705405926377,"PPP2CA/CTNNB1",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0458063135364042,0.0268705405926377,"PPP2CA/CTNNB1",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0458063135364042,0.0268705405926377,"PPP2CA/CTNNB1",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/35","14/2914",0.0116517030548912,0.0458063135364042,0.0268705405926377,"PPP2CA/CTNNB1",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","3/35","41/2914",0.0123860232566075,0.04796091712145,0.028134457258776,"SRC/JAK2/STAT1",3
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","3/35","41/2914",0.0123860232566075,0.04796091712145,0.028134457258776,"MAPK1/PPP2CA/SRC",3
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/35","42/2914",0.0132301205359254,0.048055498338936,0.0281899397512001,"MAPK1/SRC/JAK2",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/35","42/2914",0.0132301205359254,0.048055498338936,0.0281899397512001,"MAPK1/SRC/JAK2",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/35","42/2914",0.0132301205359254,0.048055498338936,0.0281899397512001,"MAPK1/SRC/JAK2",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/35","42/2914",0.0132301205359254,0.048055498338936,0.0281899397512001,"MAPK1/SRC/JAK2",3
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","4/35","78/2914",0.0132532430451014,0.048055498338936,0.0281899397512001,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","4/35","78/2914",0.0132532430451014,0.048055498338936,0.0281899397512001,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","4/35","78/2914",0.0132532430451014,0.048055498338936,0.0281899397512001,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/35","15/2914",0.01334356555819,0.048055498338936,0.0281899397512001,"CDK1/TP53",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/35","15/2914",0.01334356555819,0.048055498338936,0.0281899397512001,"CDK1/E2F1",2
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","2/35","15/2914",0.01334356555819,0.048055498338936,0.0281899397512001,"SRC/CTNNB1",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/35","80/2914",0.014447503784005,0.0516698920052957,0.0303101870322327,"HIF1A/AR/SMAD3/TP53",4
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","5/35","124/2914",0.014980145869083,0.0519657003551603,0.0304837118077282,"HIF1A/AR/CDK1/SMAD3/TP53",5
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","3/35","44/2914",0.0150154817682019,0.0519657003551603,0.0304837118077282,"MAPK1/E2F1/TP53",3
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/35","16/2914",0.0151356408801438,0.0519657003551603,0.0304837118077282,"PPP2CA/CTNNB1",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/35","16/2914",0.0151356408801438,0.0519657003551603,0.0304837118077282,"SRC/CSNK2A1",2
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","2/35","16/2914",0.0151356408801438,0.0519657003551603,0.0304837118077282,"MAPK1/PRKCD",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/35","16/2914",0.0151356408801438,0.0519657003551603,0.0304837118077282,"CDK1/TP53",2
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","3/35","45/2914",0.0159570816241016,0.0544231591815386,0.0319252870415975,"MAPK1/RELA/CDK2",3
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","4/35","83/2914",0.016364563405461,0.0554457246961342,0.0325251364083608,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/35","46/2914",0.0169314860077978,0.0558879502651595,0.0327845513052648,"MAPK1/SRC/JAK2",3
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","3/35","46/2914",0.0169314860077978,0.0558879502651595,0.0327845513052648,"CDK1/TP53/SUMO1",3
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","2/35","17/2914",0.0170254207917693,0.0558879502651595,0.0327845513052648,"SUMO1/PIAS2",2
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","4/35","84/2914",0.0170376858089904,0.0558879502651595,0.0327845513052648,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","4/35","84/2914",0.0170376858089904,0.0558879502651595,0.0327845513052648,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","3/35","47/2914",0.0179388153018851,0.0577405617529426,0.0338713157344804,"MAPK1/CREB1/SRC",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/35","47/2914",0.0179388153018851,0.0577405617529426,0.0338713157344804,"HIF1A/CDK2/AKT1",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/35","47/2914",0.0179388153018851,0.0577405617529426,0.0338713157344804,"HIF1A/CDK2/AKT1",3
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","4/35","86/2914",0.0184359150604169,0.0578932698543581,0.033960896163926,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","4/35","86/2914",0.0184359150604169,0.0578932698543581,0.033960896163926,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","4/35","86/2914",0.0184359150604169,0.0578932698543581,0.033960896163926,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","4/35","86/2914",0.0184359150604169,0.0578932698543581,0.033960896163926,"MYB/SRC/CSNK2A1/GATA1",4
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/35","18/2914",0.0190104398704978,0.0583908903297565,0.034252806386592,"MAPK1/CREB1",2
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","2/35","18/2914",0.0190104398704978,0.0583908903297565,0.034252806386592,"E2F1/MAX",2
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","4/35","87/2914",0.0191612824577259,0.0583908903297565,0.034252806386592,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","4/35","87/2914",0.0191612824577259,0.0583908903297565,0.034252806386592,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","4/35","87/2914",0.0191612824577259,0.0583908903297565,0.034252806386592,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","3/35","49/2914",0.0200526401347948,0.0603924542071305,0.0354269480990219,"MAPK1/CREB1/SRC",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/35","49/2914",0.0200526401347948,0.0603924542071305,0.0354269480990219,"MAPK1/SRC/JAK2",3
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","2/35","19/2914",0.0210882748803125,0.0629886316310259,0.036949897349217,"SRC/PRKCD",2
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","3/35","50/2914",0.0211592879071213,0.0629886316310259,0.036949897349217,"MAPK1/PPP2CA/SRC",3
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","4/35","90/2914",0.0214438607459867,0.0631062187667608,0.0370188753930718,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","4/35","90/2914",0.0214438607459867,0.0631062187667608,0.0370188753930718,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/35","92/2914",0.0230554368599458,0.0672871923729885,0.0394714853572768,"MAPK1/PPP2CA/SRC/AKT1",4
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/35","20/2914",0.0232565441599844,0.0672871923729885,0.0394714853572768,"MAPK1/SRC",2
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","2/35","20/2914",0.0232565441599844,0.0672871923729885,0.0394714853572768,"MAPK1/CSNK2A1",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/35","52/2914",0.0234723092415067,0.0675320629015416,0.0396151293873121,"HIF1A/CREB1/CSNK1D",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","3/35","53/2914",0.024678736605622,0.070218504706604,0.0411910288212475,"MAPK1/SRC/CSNK2A1",3
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","3/35","53/2914",0.024678736605622,0.070218504706604,0.0411910288212475,"SRC/PRKCD/RELA",3
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","2/35","21/2914",0.025512907019309,0.0717986181144488,0.0421179425627937,"PRKCD/CTNNB1",2
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","2/35","21/2914",0.025512907019309,0.0717986181144488,0.0421179425627937,"MAPK1/PPP2CA",2
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","5/35","144/2914",0.0269297701345691,0.0753740848875169,0.0442153548548132,"SRC/CSNK1D/AKT3/AKT1/AKT2",5
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","3/35","55/2914",0.0271914441328965,0.0756951012348199,0.0444036669481723,"MAPK1/PPP2CA/SRC",3
"R-HSA-180024","R-HSA-180024","DARPP-32 events","2/35","22/2914",0.0278550631432467,0.0759013625331856,0.0445246623342345,"PPP2CA/CDK5",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/35","22/2914",0.0278550631432467,0.0759013625331856,0.0445246623342345,"MAPK1/CREB1",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/35","22/2914",0.0278550631432467,0.0759013625331856,0.0445246623342345,"CDK2/TP53",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/35","22/2914",0.0278550631432467,0.0759013625331856,0.0445246623342345,"CDK2/TP53",2
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/35","23/2914",0.030280752003871,0.0808009703730237,0.0473988318795254,"E2F1/TP53",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/35","23/2914",0.030280752003871,0.0808009703730237,0.0473988318795254,"SUMO1/PIAS2",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/35","23/2914",0.030280752003871,0.0808009703730237,0.0473988318795254,"JAK2/STAT1",2
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","2/35","23/2914",0.030280752003871,0.0808009703730237,0.0473988318795254,"E2F1/CDK2",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/35","24/2914",0.0327877522800303,0.0861514919602836,0.0505375129128286,"CDK2/TP53",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/35","24/2914",0.0327877522800303,0.0861514919602836,0.0505375129128286,"CDK2/TP53",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/35","24/2914",0.0327877522800303,0.0861514919602836,0.0505375129128286,"JAK2/STAT1",2
"R-HSA-450294","R-HSA-450294","MAP kinase activation","3/35","60/2914",0.0340541904173964,0.0888660920077268,0.0521299303141903,"MAPK1/CREB1/PPP2CA",3
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"CREB1/PRKCD",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"CREB1/PRKCD",2
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"SRC/AKT1",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"CDK1/CSNK1D",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"CDK1/CSNK1D",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"MAPK1/SRC",2
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"SRC/CDK5",2
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","2/35","25/2914",0.0353738812846291,0.0888660920077268,0.0521299303141903,"SRC/AKT1",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/35","62/2914",0.0370303036533544,0.092575759133386,0.0543060661651135,"MAPK1/SRC/PRKCD",3
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","9/35","393/2914",0.0378653130463008,0.0928391095531296,0.0544605507240638,"HIF1A/AR/CDK1/SMAD3/RELA/CSNK1D/TP53/SUMO1/PIAS2",9
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/35","26/2914",0.0380369943994376,0.0928391095531296,0.0544605507240638,"AKT1/AKT2",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/35","26/2914",0.0380369943994376,0.0928391095531296,0.0544605507240638,"CDK1/CSNK1D",2
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","2/35","26/2914",0.0380369943994376,0.0928391095531296,0.0544605507240638,"PRKCD/CTNNB1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/35","26/2914",0.0380369943994376,0.0928391095531296,0.0544605507240638,"CDK1/CSNK1D",2
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","4/35","109/2914",0.0397580950103315,0.0953370107489619,0.0559258499436935,"PPP2CA/PRKCD/CSNK1D/AKT1",4
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","5/35","160/2914",0.0400123507442619,0.0953370107489619,0.0559258499436935,"SRC/CSNK1D/AKT3/AKT1/AKT2",5
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","3/35","64/2914",0.0401372288851415,0.0953370107489619,0.0559258499436935,"MAPK1/CREB1/PPP2CA",3
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/35","27/2914",0.0407749845173355,0.0953370107489619,0.0559258499436935,"CDK1/CSNK1D",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/35","27/2914",0.0407749845173355,0.0953370107489619,0.0559258499436935,"CDK1/CSNK1D",2
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","2/35","27/2914",0.0407749845173355,0.0953370107489619,0.0559258499436935,"PIAS2/KDM6A",2
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","2/35","27/2914",0.0407749845173355,0.0953370107489619,0.0559258499436935,"PIAS2/KDM6A",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/35","27/2914",0.0407749845173355,0.0953370107489619,0.0559258499436935,"CDK1/TP53",2
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","2/35","27/2914",0.0407749845173355,0.0953370107489619,0.0559258499436935,"MYB/GATA1",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","4/35","110/2914",0.040911610437904,0.0953370107489619,0.0559258499436935,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","6/35","217/2914",0.0417106161004793,0.0967611139267877,0.0567612461869966,"MAPK1/CREB1/PPP2CA/SRC/PRKCD/CDK5",6
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/35","28/2914",0.0435857814919029,0.100657746494753,0.0590470582401517,"CDK1/CSNK1D",2
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/35","29/2914",0.0464673515942661,0.106358604760209,0.0623912510294941,"SRC/STAT1",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/35","29/2914",0.0464673515942661,0.106358604760209,0.0623912510294941,"E2F1/TP53",2
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/35","30/2914",0.0494176969771115,0.111623306768476,0.0654795892540674,"CREB1/PRKCD",2
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","2/35","30/2914",0.0494176969771115,0.111623306768476,0.0654795892540674,"CSNK2A1/TP53",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/35","30/2914",0.0494176969771115,0.111623306768476,0.0654795892540674,"PPP2CA/CTNNB1",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","6/35","228/2914",0.0511661091668599,0.115067887427654,0.0675002221599117,"AR/MAPK1/PPP2CA/SRC/PRKCD/CTNNB1",6
"R-HSA-195721","R-HSA-195721","Signaling by WNT","5/35","172/2914",0.0520340704385944,0.115896782832947,0.0679864622852446,"PPP2CA/CSNK2A1/CTNNB1/AKT1/AKT2",5
"R-HSA-391251","R-HSA-391251","Protein folding","2/35","31/2914",0.0524348551457801,0.115896782832947,0.0679864622852446,"CSNK2A1/TP53",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/35","31/2914",0.0524348551457801,0.115896782832947,0.0679864622852446,"PRKCD/AKT1",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/35","31/2914",0.0524348551457801,0.115896782832947,0.0679864622852446,"PPP2CA/CTNNB1",2
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","3/35","72/2914",0.0538496132176992,0.118515174389381,0.069522442615743,"SRC/PRKCD/RELA",3
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/35","32/2914",0.0555168984363555,0.121149163960691,0.0710675729314632,"JAK2/STAT1",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/35","32/2914",0.0555168984363555,0.121149163960691,0.0710675729314632,"MAPK1/SRC",2
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","5/35","177/2914",0.0576173473430938,0.125202252665373,0.0734451640571527,"CDK1/MAPK1/PPP2CA/SRC/JAK2",5
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","2/35","33/2914",0.058661933500661,0.126405421560002,0.0741509575630465,"MAPK1/SRC",2
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","2/35","33/2914",0.058661933500661,0.126405421560002,0.0741509575630465,"SRC/AKT1",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/35","34/2914",0.0618681007980805,0.130049273106169,0.0762884851946256,"CDK1/CDK2",2
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","2/35","34/2914",0.0618681007980805,0.130049273106169,0.0762884851946256,"RELA/CTNNB1",2
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","2/35","34/2914",0.0618681007980805,0.130049273106169,0.0762884851946256,"CDK1/PPP2CA",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/35","34/2914",0.0618681007980805,0.130049273106169,0.0762884851946256,"MAPK1/SRC",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/35","34/2914",0.0618681007980805,0.130049273106169,0.0762884851946256,"MAPK1/PPP2CA",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/35","34/2914",0.0618681007980805,0.130049273106169,0.0762884851946256,"TP53/SUMO1",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","3/35","77/2914",0.0634332982415821,0.132322389150353,0.07762192271058,"MAPK1/CREB1/SRC",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","4/35","127/2914",0.063463359456577,0.132322389150353,0.07762192271058,"MAPK1/CREB1/PPP2CA/RELA",4
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/35","35/2914",0.0651335740941201,0.135257220397064,0.0793435304117677,"TP53/SUMO1",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","9/35","436/2914",0.0667822347326514,0.138123899145845,0.0810251590288351,"MAPK1/CREB1/PPP2CA/SRC/PRKCD/CDK5/AKT3/AKT1/AKT2",9
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/35","80/2914",0.0695433746570146,0.14325935179345,0.0840376780065818,"CDK1/CREB1/CSNK1D",3
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","5/35","188/2914",0.0710989855433849,0.145079129866614,0.0851051819554792,"MAPK1/PPP2CA/SRC/JAK2/AKT2",5
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","3/35","81/2914",0.0716385191956684,0.145079129866614,0.0851051819554792,"CDK2/TP53/SUMO1",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","2/35","37/2914",0.0718352973125952,0.145079129866614,0.0851051819554792,"PPP2CA/CTNNB1",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/35","37/2914",0.0718352973125952,0.145079129866614,0.0851051819554792,"CDK1/CSNK1D",2
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","2/35","37/2914",0.0718352973125952,0.145079129866614,0.0851051819554792,"SUMO1/PIAS2",2
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","2/35","38/2914",0.0752680568764405,0.151418161294402,0.0888237348829705,"SUMO1/PIAS2",2
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/35","40/2914",0.0822888819822111,0.163624610891269,0.0959841866648835,"CDK1/CDK2",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/35","40/2914",0.0822888819822111,0.163624610891269,0.0959841866648835,"CDK1/CDK2",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/35","40/2914",0.0822888819822111,0.163624610891269,0.0959841866648835,"SMAD3/AKT1",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/35","41/2914",0.0858736439681395,0.170095871706122,0.0997803069589313,"JAK2/STAT1",2
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","3/35","88/2914",0.0870943634102722,0.171852862667779,0.100810979224635,"MAPK1/CREB1/SRC",3
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/35","42/2914",0.0895058201397502,0.175268050843997,0.102814370142519,"CDK1/CSNK1D",2
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","2/35","42/2914",0.0895058201397502,0.175268050843997,0.102814370142519,"EGR1/STAT1",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","5/35","202/2914",0.0906267405383783,0.176790800671458,0.103707633710186,"CDK1/MAPK1/PPP2CA/SRC/JAK2",5
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/35","46/2914",0.104477559203022,0.203041294300212,0.119106492517447,"AR/NR0B2",2
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/35","47/2914",0.108323725598628,0.209049295265022,0.122630858949538,"PPP2CA/SRC",2
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/35","153/2914",0.108380896768468,0.209049295265022,0.122630858949538,"MAPK1/SRC/PRKCD/AKT1",4
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","2/35","48/2914",0.112208271416571,0.211165354028059,0.123872164754324,"CDK2/SUMO1",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"MAPK1",1
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"PRKCD",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"SRC",1
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"RELA",1
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"GSK3A",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"CREB1",1
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"MAPK1",1
"R-HSA-74749","R-HSA-74749","Signal attenuation","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"MAPK1",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"STAT1",1
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","1/35","10/2914",0.113988288193787,0.211165354028059,0.123872164754324,"MAPK1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","9/35","486/2914",0.115257135120067,0.212750625759263,0.124802104431086,"MAPK1/CREB1/PPP2CA/SRC/PRKCD/CDK5/AKT3/AKT1/AKT2",9
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/35","49/2914",0.116129787641327,0.212835731798162,0.124852028668518,"SRC/STAT1",2
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","2/35","49/2914",0.116129787641327,0.212835731798162,0.124852028668518,"MYB/FOXA1",2
"R-HSA-69306","R-HSA-69306","DNA Replication","2/35","51/2914",0.12407822754273,0.220630254509016,0.129424390483572,"E2F1/CDK2",2
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"RELA",1
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"SRC",1
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"CREB1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"JAK2",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"TP53",1
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"SRC",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"TP53",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"CDK1",1
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","1/35","11/2914",0.124666804004124,0.220630254509016,0.129424390483572,"JAK2",1
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/35","52/2914",0.128102464274778,0.222486997421606,0.130513578456824,"MAPK1/AKT2",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/35","52/2914",0.128102464274778,0.222486997421606,0.130513578456824,"MAPK1/AKT2",2
"R-HSA-112316","R-HSA-112316","Neuronal System","3/35","105/2914",0.129860808857061,0.222486997421606,0.130513578456824,"MAPK1/CREB1/SRC",3
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","2/35","53/2914",0.132158296732392,0.222486997421606,0.130513578456824,"SRC/CSNK2A1",2
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"MAPK1",1
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CREB1",1
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CSNK2A1",1
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"SMAD3",1
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"MAPK1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"STAT1",1
"R-HSA-204005","R-HSA-204005","COPII-mediated vesicle transport","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CSNK1D",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CDK1",1
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"GSK3A",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CREB1",1
"R-HSA-6791226","R-HSA-6791226","Major pathway of rRNA processing in the nucleolus and cytosol","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CSNK1D",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CDK2",1
"R-HSA-72312","R-HSA-72312","rRNA processing","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CSNK1D",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"RELA",1
"R-HSA-8868773","R-HSA-8868773","rRNA processing in the nucleus and cytosol","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CSNK1D",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/35","12/2914",0.13522025280187,0.222486997421606,0.130513578456824,"CREB1",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","6/35","296/2914",0.137716372727081,0.224580177374292,0.131741463273218,"PPP2CA/SRC/RELA/AKT3/AKT1/AKT2",6
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","2/35","55/2914",0.14035965217538,0.224580177374292,0.131741463273218,"PPP2CA/STK11",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","3/35","109/2914",0.140870931708482,0.224580177374292,0.131741463273218,"RELA/JAK2/KDM6A",3
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","3/35","109/2914",0.140870931708482,0.224580177374292,0.131741463273218,"RELA/JAK2/KDM6A",3
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"CREB1",1
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"MAPK1",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"SRC",1
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"RELA",1
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"SRC",1
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"SRC",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"SUMO1",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"PPP2CA",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"PPP2CA",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"PPP2CA",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"PPP2CA",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"PPP2CA",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"PPP2CA",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"CTNNB1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"TP53",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"CDK2",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/35","13/2914",0.14565005678255,0.224580177374292,0.131741463273218,"STK11",1
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","4/35","171/2914",0.146158542440608,0.224691490617651,0.131806760975505,"MAPK1/PPP2CA/SRC/JAK2",4
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","2/35","57/2914",0.148672344039191,0.227875765417212,0.133674695298395,"SRC/CTNNB1",2
"R-HSA-3214858","R-HSA-3214858","RMTs methylate histone arginines","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"JAK2",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"CTNNB1",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"E2F1",1
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"JAK2",1
"R-HSA-927802","R-HSA-927802","Nonsense-Mediated Decay (NMD)","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"PPP2CA",1
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"SMAD3",1
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"SRC",1
"R-HSA-975957","R-HSA-975957","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)","1/35","14/2914",0.155957622453909,0.233483068499311,0.136964007479412,"PPP2CA",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","2/35","59/2914",0.157086803693143,0.234491895368025,0.137555797589419,"CDK2/SUMO1",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/35","61/2914",0.165593832031993,0.238340767448065,0.139813592759519,"SRC/CSNK2A1",2
"R-HSA-1170546","R-HSA-1170546","Prolactin receptor signaling","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"JAK2",1
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"SMAD3",1
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"SRC",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"CDK1",1
"R-HSA-3214842","R-HSA-3214842","HDMs demethylate histones","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"KDM6A",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"AR",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"PPP2CA",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"TP53",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"TP53",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"CDK5",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"CDK5",1
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"SMAD3",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/35","15/2914",0.166144340803603,0.238340767448065,0.139813592759519,"AKT1",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","2/35","63/2914",0.174184588115741,0.246600455284133,0.144658826094116,"CDK2/SUMO1",2
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"MAPK1",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"CDK2",1
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"RELA",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"SRC",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"RELA",1
"R-HSA-6788467","R-HSA-6788467","IL-6-type cytokine receptor ligand interactions","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"JAK2",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"SRC",1
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","1/35","16/2914",0.176211587465167,0.246600455284133,0.144658826094116,"SRC",1
"R-HSA-422475","R-HSA-422475","Axon guidance","5/35","254/2914",0.184564910520077,0.254304435767535,0.14917807473742,"MAPK1/CREB1/SRC/CSNK2A1/CDK5",5
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"CDK1",1
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"SRC",1
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"PRKCD",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"SRC",1
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"SUMO1",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"RELA",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"CDK2",1
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","1/35","17/2914",0.186160722882254,0.254304435767535,0.14917807473742,"SMAD3",1
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/35","18/2914",0.195993092471181,0.264925046253696,0.155408254010855,"HIF1A",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/35","18/2914",0.195993092471181,0.264925046253696,0.155408254010855,"STK11",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/35","18/2914",0.195993092471181,0.264925046253696,0.155408254010855,"CSNK2A1",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/35","18/2914",0.195993092471181,0.264925046253696,0.155408254010855,"STAT1",1
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","1/35","19/2914",0.205710026781785,0.273748485252246,0.160584190633407,"RELA",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/35","19/2914",0.205710026781785,0.273748485252246,0.160584190633407,"CDK1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/35","19/2914",0.205710026781785,0.273748485252246,0.160584190633407,"CTNNB1",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/35","19/2914",0.205710026781785,0.273748485252246,0.160584190633407,"RELA",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/35","19/2914",0.205710026781785,0.273748485252246,0.160584190633407,"CSNK2A1",1
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","1/35","19/2914",0.205710026781785,0.273748485252246,0.160584190633407,"SMAD3",1
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"SRC",1
"R-HSA-199977","R-HSA-199977","ER to Golgi Anterograde Transport","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"CSNK1D",1
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"SMAD3",1
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"RELA",1
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"RELA",1
"R-HSA-70171","R-HSA-70171","Glycolysis","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"PPP2CA",1
"R-HSA-70326","R-HSA-70326","Glucose metabolism","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"PPP2CA",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/35","20/2914",0.215312841656616,0.280724337856095,0.164676310607459,"GATA1",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/35","21/2914",0.224802838388482,0.290888094899669,0.170638494095462,"SRC",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/35","21/2914",0.224802838388482,0.290888094899669,0.170638494095462,"SUMO1",1
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","1/35","21/2914",0.224802838388482,0.290888094899669,0.170638494095462,"RELA",1
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","1/35","22/2914",0.23418130387635,0.29778610246005,0.174684949220305,"PRKCD",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/35","22/2914",0.23418130387635,0.29778610246005,0.174684949220305,"CDK2",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/35","22/2914",0.23418130387635,0.29778610246005,0.174684949220305,"CDK2",1
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","1/35","22/2914",0.23418130387635,0.29778610246005,0.174684949220305,"CTNNB1",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/35","22/2914",0.23418130387635,0.29778610246005,0.174684949220305,"SMAD3",1
"R-HSA-525793","R-HSA-525793","Myogenesis","1/35","22/2914",0.23418130387635,0.29778610246005,0.174684949220305,"CTNNB1",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/35","22/2914",0.23418130387635,0.29778610246005,0.174684949220305,"CREB1",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/35","23/2914",0.243449510779645,0.307295338361561,0.180263182646435,"SRC",1
"R-HSA-9020591","R-HSA-9020591","Interleukin-12 signaling","1/35","23/2914",0.243449510779645,0.307295338361561,0.180263182646435,"JAK2",1
"R-HSA-948021","R-HSA-948021","Transport to the Golgi and subsequent modification","1/35","23/2914",0.243449510779645,0.307295338361561,0.180263182646435,"CSNK1D",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","7/35","428/2914",0.246712302722425,0.310652410518457,0.182232482000608,"MAPK1/CREB1/PPP2CA/SRC/PRKCD/RELA/CTNNB1",7
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"RELA",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"HIF1A",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"CDK2",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"STAT1",1
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"SMAD3",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"AR",1
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"JAK2",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/35","24/2914",0.252608717670932,0.311974795205108,0.183008208939941,"STAT1",1
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/35","82/2914",0.258479245584488,0.318461271473712,0.186813254804201,"SMAD3/RELA",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","1/35","25/2914",0.261660169187028,0.320845207455523,0.188211700643301,"MAPK1",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/35","25/2914",0.261660169187028,0.320845207455523,0.188211700643301,"SUMO1",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/35","26/2914",0.270605096178532,0.330240816426407,0.193723279130054,"STAT1",1
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","1/35","26/2914",0.270605096178532,0.330240816426407,0.193723279130054,"JAK2",1
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","1/35","27/2914",0.279444715857809,0.33624773052984,0.197247007996043,"SRC",1
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/35","27/2914",0.279444715857809,0.33624773052984,0.197247007996043,"CDK1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/35","27/2914",0.279444715857809,0.33624773052984,0.197247007996043,"RELA",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/35","27/2914",0.279444715857809,0.33624773052984,0.197247007996043,"SUMO1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/35","27/2914",0.279444715857809,0.33624773052984,0.197247007996043,"CDK2",1
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","1/35","27/2914",0.279444715857809,0.33624773052984,0.197247007996043,"SRC",1
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","2/35","87/2914",0.281029268350924,0.33736613799703,0.197903079417777,"MAPK1/RELA",2
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/35","28/2914",0.288180231945435,0.344345288751506,0.201997134127097,"CDK1",1
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","1/35","28/2914",0.288180231945435,0.344345288751506,0.201997134127097,"SMAD3",1
"R-HSA-73894","R-HSA-73894","DNA Repair","3/35","157/2914",0.291202926408741,0.347151636806717,0.203643372025606,"CDK2/TP53/SUMO1",3
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","1/35","29/2914",0.29681283481512,0.348992260113668,0.204723104042152,"PPP2CA",1
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","1/35","29/2914",0.29681283481512,0.348992260113668,0.204723104042152,"PPP2CA",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/35","29/2914",0.29681283481512,0.348992260113668,0.204723104042152,"CDK1",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/35","29/2914",0.29681283481512,0.348992260113668,0.204723104042152,"CREB1",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/35","29/2914",0.29681283481512,0.348992260113668,0.204723104042152,"GSK3A",1
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","1/35","29/2914",0.29681283481512,0.348992260113668,0.204723104042152,"PRKCD",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/35","30/2914",0.30534370163712,0.354970668946087,0.208230111369498,"CSNK2A1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/35","30/2914",0.30534370163712,0.354970668946087,0.208230111369498,"CDK1",1
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","1/35","30/2914",0.30534370163712,0.354970668946087,0.208230111369498,"MAPK1",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/35","30/2914",0.30534370163712,0.354970668946087,0.208230111369498,"TP53",1
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","1/35","30/2914",0.30534370163712,0.354970668946087,0.208230111369498,"SUMO1",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/35","31/2914",0.313773996520164,0.362317507192566,0.212539856033248,"AKT1",1
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","1/35","31/2914",0.313773996520164,0.362317507192566,0.212539856033248,"RELA",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/35","31/2914",0.313773996520164,0.362317507192566,0.212539856033248,"STAT1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/35","165/2914",0.318048512895706,0.366431731859707,0.214953310258019,"MAPK1/CREB1/PRKCD",3
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/35","32/2914",0.3221048706519,0.368631129746064,0.216243503806071,"CREB1",1
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","1/35","32/2914",0.3221048706519,0.368631129746064,0.216243503806071,"MAPK1",1
"R-HSA-8853659","R-HSA-8853659","RET signaling","1/35","32/2914",0.3221048706519,0.368631129746064,0.216243503806071,"SRC",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/35","33/2914",0.330337462437876,0.37721461897008,0.22127868297274,"CDK2",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/35","34/2914",0.338472897639082,0.38226654009677,0.224242201344452,"STAT1",1
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","1/35","34/2914",0.338472897639082,0.38226654009677,0.224242201344452,"SRC",1
"R-HSA-446203","R-HSA-446203","Asparagine N-linked glycosylation","1/35","34/2914",0.338472897639082,0.38226654009677,0.224242201344452,"CSNK1D",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/35","34/2914",0.338472897639082,0.38226654009677,0.224242201344452,"CDK1",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/35","34/2914",0.338472897639082,0.38226654009677,0.224242201344452,"TP53",1
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/35","35/2914",0.346512289508052,0.388788298685505,0.228067944246785,"STAT1",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/35","35/2914",0.346512289508052,0.388788298685505,0.228067944246785,"SRC",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/35","35/2914",0.346512289508052,0.388788298685505,0.228067944246785,"CTNNB1",1
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","1/35","36/2914",0.35445673892355,0.395976617235636,0.232284699328825,"SMAD3",1
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","1/35","36/2914",0.35445673892355,0.395976617235636,0.232284699328825,"SRC",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/35","37/2914",0.362307334523854,0.403870730042824,0.23691548190555,"STAT1",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/35","38/2914",0.370065152838649,0.409857104756783,0.240427162115885,"CREB1",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/35","38/2914",0.370065152838649,0.409857104756783,0.240427162115885,"RELA",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/35","38/2914",0.370065152838649,0.409857104756783,0.240427162115885,"CDK5",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","1/35","39/2914",0.377731258419541,0.417449781300566,0.244881118514589,"RELA",1
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","1/35","40/2914",0.385306703969217,0.423097979838266,0.24819442046721,"HIF1A",1
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","1/35","40/2914",0.385306703969217,0.423097979838266,0.24819442046721,"RELA",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/35","40/2914",0.385306703969217,0.423097979838266,0.24819442046721,"CTNNB1",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/35","41/2914",0.392792530469244,0.430400325939703,0.252478065497588,"CREB1",1
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/35","42/2914",0.400189767306548,0.433889958237626,0.254525126242614,"AKT2",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/35","42/2914",0.400189767306548,0.433889958237626,0.254525126242614,"CTNNB1",1
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","1/35","42/2914",0.400189767306548,0.433889958237626,0.254525126242614,"SRC",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/35","42/2914",0.400189767306548,0.433889958237626,0.254525126242614,"PPP2CA",1
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","1/35","42/2914",0.400189767306548,0.433889958237626,0.254525126242614,"PPP2CA",1
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","1/35","43/2914",0.407499432398565,0.439962699549813,0.258087470149814,"RELA",1
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","1/35","43/2914",0.407499432398565,0.439962699549813,0.258087470149814,"MAPK1",1
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","1/35","44/2914",0.414722532317077,0.444037638551548,0.260477878925487,"SRC",1
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","1/35","44/2914",0.414722532317077,0.444037638551548,0.260477878925487,"SRC",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/35","44/2914",0.414722532317077,0.444037638551548,0.260477878925487,"CDK2",1
"R-HSA-71387","R-HSA-71387","Metabolism of carbohydrates","1/35","44/2914",0.414722532317077,0.444037638551548,0.260477878925487,"PPP2CA",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/35","45/2914",0.421860062410771,0.449809383315833,0.263863654597126,"STAT1",1
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","1/35","45/2914",0.421860062410771,0.449809383315833,0.263863654597126,"JAK2",1
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/35","46/2914",0.428913006926499,0.45544370838587,0.267168818204895,"AKT2",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/35","46/2914",0.428913006926499,0.45544370838587,0.267168818204895,"SUMO1",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/35","48/2914",0.442769021421039,0.469189395127233,0.275232205215157,"RELA",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/35","125/2914",0.447254794917566,0.472969649656153,0.27744974849528,"MAPK1/PRKCD",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","1/35","49/2914",0.449574005458116,0.474447977071578,0.278316953335805,"MAPK1",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/35","126/2914",0.451389494061519,0.475389753459473,0.278869410818332,"SRC/CTNNB1",2
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/35","50/2914",0.456298232267529,0.479578754321994,0.281326729668702,"AKT2",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","4/35","289/2914",0.462936599532072,0.482622379891584,0.283112157442789,"PPP2CA/CSNK2A1/STK11/AKT1",4
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/35","51/2914",0.462942632362024,0.482622379891584,0.283112157442789,"AKT2",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/35","51/2914",0.462942632362024,0.482622379891584,0.283112157442789,"AKT2",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/35","51/2914",0.462942632362024,0.482622379891584,0.283112157442789,"HIF1A",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/35","55/2914",0.488740214188515,0.508487293549667,0.298284830350035,"SUMO1",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","1/35","56/2914",0.494999078303032,0.513960736544479,0.301495618575913,"PPP2CA",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/35","57/2914",0.501183484272029,0.519334998792947,0.304648226169802,"RELA",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/35","59/2914",0.513332352275554,0.530855745827129,0.311406436489292,"RELA",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/35","60/2914",0.519298505575153,0.53594935946133,0.314394412192952,"PPP2CA",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/35","61/2914",0.525193583467539,0.540949390971565,0.317327491484597,"PPP2CA",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/35","62/2914",0.531018408065729,0.545857245816069,0.320206498823121,"SRC",1
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","1/35","63/2914",0.536773792258471,0.549579528853106,0.322390035321086,"SMAD3",1
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","1/35","63/2914",0.536773792258471,0.549579528853106,0.322390035321086,"RELA",1
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","1/35","64/2914",0.542460539810541,0.553202332678077,0.32451521610344,"HIF1A",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/35","64/2914",0.542460539810541,0.553202332678077,0.32451521610344,"SRC",1
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","1/35","66/2914",0.55363129502634,0.563478491973449,0.330543336119325,"RELA",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","1/35","68/2914",0.564536925097132,0.573444805572038,0.336389696881298,"SRC",1
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","1/35","69/2914",0.569892233467336,0.577745079204091,0.338912289691516,"SRC",1
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/35","72/2914",0.585577119669315,0.592479796914926,0.347555854296543,"SRC",1
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/35","73/2914",0.590680849722649,0.59647183844542,0.349897634407431,"SRC",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/35","76/2914",0.605628393868229,0.60917699773855,0.357350635362215,"RELA",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/35","76/2914",0.605628393868229,0.60917699773855,0.357350635362215,"CTNNB1",1
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","1/35","86/2914",0.651721612006922,0.654262437005,0.383798302341206,"SMAD3",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/35","106/2914",0.728737477880435,0.730155255074755,0.428317952389279,"RELA",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","1/35","119/2914",0.769631532239085,0.769631532239085,0.4514752166635,"CSNK2A1",1
